Director, Chief Executive Officer · Mineralys Therapeutics, Inc. · Common Stock
Side
SELL
Value
$294K
Shares
9,119
Price
$32.21
Executed
Jan 12, 2026
Disclosed
Jan 13, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 12 executedJan 13, 2026 disclosed
MLYS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 6 prior trades recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Congleton Jon filed this Form 4 reporting a open-market sale of MLYS on Jan 12, 2026. It became public on Jan 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Congleton Joncik:0001644975
Issuer
Mineralys Therapeutics, Inc.cik:0001933414
Revision history · 0
No field has changed since this record was first ingested.
